SAS Output

S1609 FAQ

UPCOMING DART COHORT CLOSURES AS OF 26-APR-2018 6:10 AM

The REPORT Procedure

Detailed and/or summarized report

Table 1

# COHORT Name Up-coming
Closure Date
Closure Type
6 Squamous cell carcinoma with variants of GI tract (stomach small intestine, colon, rectum, pancreas) 05/03/2018 Temporary
17 Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis 05/08/2018 Temporary

CLOSED DART COHORTS AS OF 26-APR-2018 6:10 AM

The REPORT Procedure

Detailed and/or summarized report

Table 1

Closure Type # COHORT NAME TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
# of
ACT.
INSTs
# of
CURR
IRBs
Temporary Close 1 Epithelial tumors of nasal cavity, sinuses, nasopharynx 7 7 5 3 0 0 340 158
Permanent Close 2 Epithelial tumors of major salivary glands 20 19 15 9 0 0    
Temporary Close 3 Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location 16 16 16 3 0 0    
Permanent Close 7 Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary 10 10 0 0 0 0    
Permanent Close 9 Intrahepatic cholangiocarcinoma 9 6 0 0 0 0    
Permanent Close 10 Extrahepatic cholangiocarcinoma and bile duct tumors 10 8 1 0 0 0    
Permanent Close 13 Non-epithelial tumors of the ovary 23 22 17 12 2 0    
Temporary Close 16 Cell tumor of the testes and extragonadal germ tumors 10 9 9 5 0 0    
Temporary Close 20 Adenocarcinoma with variants of GU system (excluding prostate cancer) 9 9 9 7 0 0    
Temporary Close 22 Endocrine carcinoma of pancreas and digestive tract 10 9 8 0 0 0    
Permanent Close 23 Neuroendocrine carcinoma including carcinoid of the lung 34 33 21 0 0 0    
Temporary Close 26 Carcinomas of pituitary gland, thyroid gland parathyroid gland and adrenal cortex 14 14 11 0 0 0    
Temporary Close 27 Desmoid tumors 10 10 9 8 3 0    
Temporary Close 28 Peripheral nerve sheath tumors and NF1-related tumors 8 8 7 3 0 0    
Permanent Close 32 Tumor of unknown primary (Cancer of Unknown Primary; CuP) 21 18 11 0 0 0    
Permanent Close 34 Adenoid cystic carcinoma 23 17 11 0 0 0    
Temporary Close 35 Vulvar cancer 9 9 9 6 0 0    
Temporary Close 37 Gastrointestinal stromal tumor (GIST) 12 12 12 9 7 0    

DART ACCRUAL REPORT

The REPORT Procedure

Detailed and/or summarized report

Table 1

Status # COHORT NAME TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
# of
ACT.
INSTs
# of
CURR
IRBs
Temporary Close 1 Epithelial tumors of nasal cavity, sinuses, nasopharynx 7 7 5 3 0 0 340 158
Permanent Close 2 Epithelial tumors of major salivary glands 20 19 15 9 0 0    
Temporary Close 3 Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location 16 16 16 3 0 0    
Open 4 Undifferentiated carcinoma of gastrointestinal (GI) tract 2 2 1 1 0 0    
Open 5 Adenocarcinoma with variants of small intestine 20 17 15 7 7 4    
Open 6 Squamous cell carcinoma with variants of GI tract (stomach small intestine, colon, rectum, pancreas) 6 4 4 4 1 0    
Permanent Close 7 Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary 10 10 0 0 0 0    
Open 8 Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma 7 6 3 2 0 0    
Permanent Close 9 Intrahepatic cholangiocarcinoma 9 6 0 0 0 0    
Permanent Close 10 Extrahepatic cholangiocarcinoma and bile duct tumors 10 8 1 0 0 0    
Open 11 Sarcomatoid carcinoma of lung 3 3 3 2 1 0    
Open 12 Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma) 4 4 4 4 1 0    
Permanent Close 13 Non-epithelial tumors of the ovary 23 22 17 12 2 0    
Open 14 Trophoblastic tumor 2 2 2 0 0 0    
Open 15 Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder 1 1 1 0 0 0    
Temporary Close 16 Cell tumor of the testes and extragonadal germ tumors 10 9 9 5 0 0    
Open 17 Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis 7 7 7 7 4 1    
Open 18 Squamous cell carcinoma variants of the genitourinary (GU) system 4 4 4 2 0 0    
Open 19 Spindle cell carcinoma of kidney, pelvis, ureter 3 3 3 2 0 0    
Temporary Close 20 Adenocarcinoma with variants of GU system (excluding prostate cancer) 9 9 9 7 0 0    
Open 21 Odontogenic malignant tumors 1 1 1 1 0 0    
Temporary Close 22 Endocrine carcinoma of pancreas and digestive tract 10 9 8 0 0 0    
Permanent Close 23 Neuroendocrine carcinoma including carcinoid of the lung 34 33 21 0 0 0    
Open 24 Pheochromocytoma, malignant 5 5 3 3 0 0    
Open 25 Paraganglioma 3 3 1 1 0 0    
Temporary Close 26 Carcinomas of pituitary gland, thyroid gland parathyroid gland and adrenal cortex 14 14 11 0 0 0    
Temporary Close 27 Desmoid tumors 10 10 9 8 3 0    
Temporary Close 28 Peripheral nerve sheath tumors and NF1-related tumors 8 8 7 3 0 0    
Open 29 Malignant giant cell tumors 2 2 2 2 1 1    
Open 30 Chordoma 8 8 6 0 0 0    
Open 31 Adrenal cortical tumors 10 10 6 2 2 1    
Permanent Close 32 Tumor of unknown primary (Cancer of Unknown Primary; CuP) 21 18 11 0 0 0    
Open 33 Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs 117 114 97 70 25 6    
Permanent Close 34 Adenoid cystic carcinoma 23 17 11 0 0 0    
Temporary Close 35 Vulvar cancer 9 9 9 6 0 0    
Open 36 MetaPLASTIC carcinoma (of the breast) 7 7 7 4 2 0    
Temporary Close 37 Gastrointestinal stromal tumor (GIST) 12 12 12 9 7 0    
    TOTAL 467 439 341 179 56 13